|Date: ||Thu, 11 Mar 1999 10:36:47 -0500|
|Reply-To: ||Anne Marie Smith <rainbowsoftware@PRODIGY.NET>|
|Sender: ||"SAS(r) Discussion" <SAS-L@UGA.CC.UGA.EDU>|
|From: ||Anne Marie Smith <rainbowsoftware@PRODIGY.NET>|
|Organization: ||Rainbow Communications and Software Inc.|
|Subject: ||New drug regulations affect on SAS clinical trials report work|
Have you seen today's news concerning new regulations for
drug labeling recommended by VP Al Gore?
"*** Gore to announce new medicine labels
WASHINGTON (AP) - No more squinting in despair at drugstore remedies,
wondering which cough syrup will stop your hacking, or where in all
the fine print it says to take one allergy tablet or two. Vice
President Al Gore will announce new regulations Thursday requiring
that all over-the-counter medicines have easier-to-read labels so
consumers can tell at a glance how to use the drug safely. "For
parents, the elderly and for all Americans, being able to read and
understand over-the-counter drug labels is essential to their
health," Gore said. More consumer-friendly labels "will give
Americans the information they need to prevent tens of thousands of
unnecessary hospitalizations that occur each year." "
I wonder how many more SAS reports we will have to create in
support of these regulations? This is good news for SAS contractors
and clinical programmers like some of us here.
But isn't it ironic how someone like the
VP of the US has to be concerned with problems caused by the
pharmaceutical industry. I sure am glad that top powerful people
are paying attention to some of the problems
caused by the pharmaceutical industry!
Anne Marie at Rainbow Comm and Software Inc.
org:Rainbow Communications and Software Inc.
adr:;;3 Militia Way;Fort Washington;PA;19034;USA
fn:Anne Marie Smith